Clarisse Dromain

Publications | Mémoires et thèses

La recherche avancée est accessible via Serval

Les publications peuvent être gérées en accédant à Serval via MyUnil

175 publications

Sous presse | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999 |
Clinical management of typical and atypical carcinoids/neuroendocrine tumors in ENETS centres of excellence (CoE): Survey from the ENETS lung NET task force.
Koumarianou A., Filosso P.L., Bodei L., Castano J.P., Fernandez-Cuesta L., Deroose C.M., Foll M., Dromain C., Reed N.S., Caplin M. et al. Journal of neuroendocrinology. Peer-reviewed.
Increased 68Ga-SST uptake in the uncinate pancreatic process in new digital PET/CT machine and potential association with clinical and histologic factors in NET patients.
Firsova M., Treglia G., Sempoux C., Dromain C., Prior J.O., Schaefer N., Boughdad S., 2024/06/24. EJNMMI reports, 8 (1) p. 18. Peer-reviewed.
Prospective evaluation of MR-TRG (Tumor Regression Grade) in esophageal cancer after neo-adjuvant therapy: Preliminary results.
Chapellier P., Fasquelle F., Saglietti C., Kinj R., Mantziari S., Schäfer M., Haefliger L., Jreige M., Vietti Violi N., Sempoux C. et al., 2024/02. European journal of radiology, 171 p. 111263. Peer-reviewed.
Anatomical Quantitative Volumetric Evaluation of Liver Segments in Hepatocellular Carcinoma Patients Treated with Selective Internal Radiation Therapy: Key Parameters Influencing Untreated Liver Hypertrophy.
Girardet R., Knebel J.F., Dromain C., Vietti Violi N., Tsoumakidou G., Villard N., Denys A., Halkic N., Demartines N., Kobayashi K. et al., 2024/01/30. Cancers, 16 (3). Peer-reviewed.
Use and perceived utility of [<sup>18</sup> F]FDG PET/CT in neuroendocrine neoplasms: A consensus report from the European Neuroendocrine Tumor Society (ENETS) Advisory Board Meeting 2022.
Ambrosini V., Caplin M., Castaño J.P., Christ E., Denecke T., Deroose C.M., Dromain C., Falconi M., Grozinsky-Glasberg S., Hicks R.J. et al., 2024/01. Journal of neuroendocrinology, 36 (1) pp. e13359. Peer-reviewed.
Response heterogeneity as a new biomarker of treatment response in patients with neuroendocrine tumors.
Dromain C., Pavel M., Ronot M., Schaefer N., Mandair D., Gueguen D., Cheng C., Dehaene O., Schutte K., Cahané D. et al., 2023/10. Future oncology, 19 (32) pp. 2171-2183. Peer-reviewed.
The combination of non-contrast abbreviated MRI and alpha foetoprotein has high performance for hepatocellular carcinoma screening.
Girardet R., Dubois M., Manasseh G., Jreige M., Du Pasquier C., Canniff E., Gulizia M., Bonvin M., Aleman Y., Taouli B. et al., 2023/10. European radiology, 33 (10) pp. 6929-6938. Peer-reviewed.
The use of deep learning models to predict progression-free survival in patients with neuroendocrine tumors.
Pavel M., Dromain C., Ronot M., Schaefer N., Mandair D., Gueguen D., Elvira D., Jégou S., Balazard F., Dehaene O. et al., 2023/10. Future oncology, 19 (32) pp. 2185-2199. Peer-reviewed.
Esophageal cancer T-staging on MRI: A preliminary study using cine and static MR sequences.
Haefliger L., Jreige M., Du Pasquier C., Ledoux J.B., Wagner D., Mantziari S., Shäfer M., Vietti Violi N., Dromain C., 2023/09. European journal of radiology, 166 p. 111001. Peer-reviewed.
Modeling tumor size dynamics based on real-world electronic health records and image data in advanced melanoma patients receiving immunotherapy.
Courlet P., Abler D., Guidi M., Girard P., Amato F., Vietti Violi N., Dietz M., Guignard N., Wicky A., Latifyan S. et al., 2023/08. CPT, 12 (8) pp. 1170-1181. Peer-reviewed.
European Neuroendocrine Tumor Society (ENETS) 2023 guidance paper for colorectal neuroendocrine tumours.
Rinke A., Ambrosini V., Dromain C., Garcia-Carbonero R., Haji A., Koumarianou A., van Dijkum E.N., O'Toole D., Rindi G., Scoazec J.Y. et al., 2023/06. Journal of neuroendocrinology, 35 (6) pp. e13309. Peer-reviewed.
Proposal of early CT morphological criteria for response of liver metastases to systemic treatments in gastroenteropancreatic neuroendocrine tumors: Alternatives to RECIST.
de Mestier L., Resche-Rigon M., Dromain C., Lamarca A., La Salvia A., de Baker L., Fehrenbach U., Pusceddu S., Colao A., Borbath I. et al., 2023/06. Journal of neuroendocrinology, 35 (6) pp. e13311. Peer-reviewed.
Preoperative hiatal hernia in esophageal adenocarcinoma; does it have an impact on patient outcomes?
St-Amour P., Mantziari S., Dromain C., Winiker M., Godat S., Schoepfer A., Demartines N., Schäfer M., 2023/02. Surgical oncology, 46 p. 101904. Peer-reviewed.
Imaging assessment of toxicity related to immune checkpoint inhibitors.
Berz A.M., Boughdad S., Vietti-Violi N., Digklia A., Dromain C., Dunet V., Duran R., 2023. Frontiers in immunology, 14 p. 1133207. Peer-reviewed.
Estimated Costs of the Ipilimumab-Nivolumab Therapy and Related Adverse Events in Metastatic Melanoma.
Gautron Moura B., Gerard C.L., Testart N., Caikovski M., Wicky A., Aedo-Lopez V., Berthod G., Homicsko K., Prior J.O., Dromain C. et al., 2022/12/21. Cancers, 15 (1) p. 31. Peer-reviewed.
First communication on the efficacy of combined 177Lutetium-PSMA with immunotherapy outside prostate cancer.
Digklia A., Boughdad S., Homicsko K., Dromain C., Trimech M., Dolcan A., Peters S., Prior J., Schaefer N., 2022/10. Journal for immunotherapy of cancer, 10 (10) pp. e005383. Peer-reviewed.
Cancer des voies biliaires . Thésaurus National de Cancérologie Digestive
Malka D, Blanc JF, Boudjema K, Bretagne-Bignon AL, Coriat R, de Baère T, de la Fouchardière C, Dromain C, Edeline J, Gelli M et al., 2022/07/01..
Imaging of Oligometastatic Disease.
Vietti Violi N., Hajri R., Haefliger L., Nicod-Lalonde M., Villard N., Dromain C., 2022/03/10. Cancers, 14 (6) p. 1427. Peer-reviewed.
ENETS standardized (synoptic) reporting for endoscopy in neuroendocrine tumors.
Borbath I., Pape U.F., Deprez P.H., Bartsch D.K., Caplin M., Falconi M., Garcia-Carbonero R., Grozinsky-Glasberg S., Jensen R.T., Arnold R. et al., 2022/03. Journal of neuroendocrinology, 34 (3) pp. e13105. Peer-reviewed.
ENETS standardized (synoptic) reporting for molecular imaging studies in neuroendocrine tumours.
Hicks R.J., Dromain C., de Herder W.W., Costa F.P., Deroose C.M., Frilling A., Koumarianou A., Krenning E.P., Raymond E., Bodei L. et al., 2022/03. Journal of neuroendocrinology, 34 (3) pp. e13040. Peer-reviewed.
ENETS standardized (synoptic) reporting for radiological imaging in neuroendocrine tumours.
Dromain C., Vullierme M.P., Hicks R.J., Prasad V., O'Toole D., de Herder W.W., Pavel M., Faggiano A., Kos-Kudla B., Öberg K. et al., 2022/03. Journal of neuroendocrinology, 34 (3) pp. e13044. Peer-reviewed.
Low-Dose Radiotherapy Reverses Tumor Immune Desertification and Resistance to Immunotherapy.
Herrera F.G., Ronet C., Ochoa de Olza M., Barras D., Crespo I., Andreatta M., Corria-Osorio J., Spill A., Benedetti F., Genolet R. et al., 2022/01. Cancer discovery, 12 (1) pp. 108-133. Peer-reviewed.
Tumor response assessment on imaging following immunotherapy.
Berz A.M., Dromain C., Vietti-Violi N., Boughdad S., Duran R., 2022. Frontiers in oncology, 12 p. 982983. Peer-reviewed.
Imaging of Gastric Carcinomatosis.
Saiz Martínez R., Dromain C., Vietti Violi N., 2021/11/14. Journal of clinical medicine, 10 (22) p. 5294. Peer-reviewed.
Target Heterogeneity in Oncology: The Best Predictor for Differential Response to Radioligand Therapy in Neuroendocrine Tumors and Prostate Cancer.
Puranik A.D., Dromain C., Fleshner N., Sathekge M., Pavel M., Eberhardt N., Zengerling F., Marienfeld R., Grunert M., Prasad V., 2021/07/19. Cancers, 13 (14) p. 3607. Peer-reviewed.
Novel Tumor Growth Rate Analysis in the Randomized CLARINET Study Establishes the Efficacy of Lanreotide Depot/Autogel 120 mg with Prolonged Administration in Indolent Neuroendocrine Tumors.
Dromain C., Loaiza-Bonilla A., Mirakhur B., Beveridge TJR, Fojo A.T., 2021/04. The oncologist, 26 (4) pp. e632-e638. Peer-reviewed.
Consensus on molecular imaging and theranostics in neuroendocrine neoplasms.
Ambrosini V., Kunikowska J., Baudin E., Bodei L., Bouvier C., Capdevila J., Cremonesi M., de Herder W.W., Dromain C., Falconi M. et al., 2021/03. European journal of cancer, 146 pp. 56-73. Peer-reviewed.
Functional and Radiological Imaging of Neuroendocrine Neoplasms
Dromain Clarisse, Prior John O., Schaefer Niklaus, 2021. pp. 29-53 dans The Spectrum of Neuroendocrine Neoplasia chap. 3, Springer International Publishing.
Tumor Growth Rate to Predict the Outcome of Patients with Neuroendocrine Tumors: Performance and Sources of Variability.
Dromain C., Sundin A., Najran P., Vidal Trueba H., Dioguardi Burgio M., Crona J., Opalinska M., Carvalho L., Franca R., Borg P. et al., 2021. Neuroendocrinology, 111 (9) pp. 831-839. Peer-reviewed.
The combination of hepatobiliary phase with Gd-EOB-DTPA and DWI is highly accurate for the detection and characterization of liver metastases from neuroendocrine tumor.
Hayoz R., Vietti-Violi N., Duran R., Knebel J.F., Ledoux J.B., Dromain C., 2020/12. European radiology, 30 (12) pp. 6593-6602. Peer-reviewed.
Lessons from a multicentre retrospective study of peptide receptor radionuclide therapy combined with lanreotide for neuroendocrine tumours: a need for standardised practice.
Prasad V., Srirajaskanthan R., Toumpanakis C., Grana C.M., Baldari S., Shah T., Lamarca A., Courbon F., Scheidhauer K., Baudin E. et al., 2020/09. European journal of nuclear medicine and molecular imaging, 47 (10) pp. 2358-2371. Peer-reviewed.
First-Line Selective Internal Radiation Therapy in Patients with Uveal Melanoma Metastatic to the Liver.
Ponti A., Denys A., Digklia A., Schaefer N., Hocquelet A., Knebel J.F., Michielin O., Dromain C., Duran R., 2020/03. Journal of nuclear medicine, 61 (3) pp. 350-356. Peer-reviewed.
Treatment intensification with hepatic arterial infusion chemotherapy in patients with liver-only colorectal metastases still unresectable after systemic induction chemotherapy - a randomized phase II study -- SULTAN UCGI 30/PRODIGE 53 (NCT03164655)- study protocol.
Boilève A., Maillard A., Wagner M., Dromain C., Laurent C., Bierre E.D., Le Sourd S., Audemar F., Ulusakarya A., Guerin-Meyer V. et al., 2020/01/30. BMC cancer, 20 (1) p. 74. Peer-reviewed.
Imaging of tumour response to immunotherapy.
Dromain C., Beigelman C., Pozzessere C., Duran R., Digklia A., 2020/01/03. European radiology experimental, 4 (1) p. 2. Peer-reviewed.
Tumor Growth Rate as a Validated Early Radiological Biomarker Able to Reflect Treatment-Induced Changes in Neuroendocrine Tumors: The GREPONET-2 Study.
Lamarca A., Ronot M., Moalla S., Crona J., Opalinska M., Lopez Lopez C., Pezzutti D., Najran P., Carvhalo L., Bezerra ROF et al., 2019/11/15. Clinical cancer research, 25 (22) pp. 6692-6699. Peer-reviewed.
Value of Tumor Growth Rate (TGR) as an Early Biomarker Predictor of Patients' Outcome in Neuroendocrine Tumors (NET)-The GREPONET Study.
Lamarca A., Crona J., Ronot M., Opalinska M., Lopez Lopez C., Pezzutti D., Najran P., Carvhalo L., Franca Bezerra R.O., Borg P. et al., 2019/11. The oncologist, 24 (11) pp. e1082-e1090. Peer-reviewed.
Angiomammography: A review of current evidences.
Dromain C., Vietti-Violi N., Meuwly J.Y., 2019/10. Diagnostic and interventional imaging, 100 (10) pp. 593-605. Peer-reviewed.
F-18-Dopa Positron Emission Tomography/Computed Tomography Is More Sensitive Than Whole-Body Magnetic Resonance Imaging for the Localization of Persistent/Recurrent Disease of Medullary Thyroid Cancer Patients.
Terroir M., Caramella C., Borget I., Bidault S., Dromain C., El Farsaoui K., Deandreis D., Grimaldi S., Lumbroso J., Berdelou A. et al., 2019/10. Thyroid, 29 (10) pp. 1457-1464. Peer-reviewed.
Tumor growth rate as a metric of progression, response, and prognosis in pancreatic and intestinal neuroendocrine tumors.
Dromain C., Pavel M.E., Ruszniewski P., Langley A., Massien C., Baudin E., Caplin M.E., CLARINET Study Group, 2019/01/14. BMC cancer, 19 (1) p. 66. Peer-reviewed.
Pre-treatment magnetic resonance-based texture features as potential imaging biomarkers for predicting event free survival in anal cancer treated by chemoradiotherapy.
Hocquelet A., Auriac T., Perier C., Dromain C., Meyer M., Pinaquy J.B., Denys A., Trillaud H., Denis De Senneville B., Vendrely V., 2018/07. European radiology, 28 (7) pp. 2801-2811. Peer-reviewed.
Additional value of tumour growth rate (TGR) in patients (pts) diagnosed with well-differentiated neuroendocrine tumours (NETs) achieving RECIST-defined stable disease (SD): Subgroup analysis of the GREPONET study.
Lamarca Angela, Crona Joakim, Ronot Maxime, Opalinska Marta, Lopez Lopez Carlos, Pezzutti Daniela, Carvalho Luciana, Franca Regis, Najran Pavan, de Mestier Louis et al., 2018/05/20., 2018 ASCO Annual Meeting pp. 4094-4094 dans Journal of Clinical Oncology.
Heterotopic Gastric Mucosa in a Duplication Cyst of the Common Hepatic Duct Mimicking Cholangiocarcinoma.
Sciarra A., Hessler R., Godat S., Fraga M., Dromain C., Duran R., Halkic N., Sempoux C., 2018/02. International journal of surgical pathology, 26 (1) pp. 84-88. Peer-reviewed.
Are we reproducible in measurement of NET liver metastasis?
Moalla S., Arfi Rouche J., Foulon S., Caramella C., Ternes N., Planchard D., Goere D., Ducreux M., Scoazec J.Y., Deschamps F. et al., 2017/10. Digestive and liver disease, 49 (10) pp. 1121-1127. Peer-reviewed.
Contamination artifact that mimics in-situ carcinoma on contrast-enhanced digital mammography.
Gluskin J., Click M., Fleischman R., Dromain C., Morris E.A., Jochelson M.S., 2017/10. European journal of radiology, 95 pp. 147-154. Peer-reviewed.
Immunohistochemical evaluation of two antibodies against PD-L1 and prognostic significance of PD-L1 expression in epithelioid peritoneal malignant mesothelioma: A RENAPE study.
Valmary-Degano S., Colpart P., Villeneuve L., Monnien F., M'Hamdi L., Lang Averous G., Capovilla M., Bibeau F., Laverriere M.H., Verriele-Beurrier V. et al., 2017/10. European journal of surgical oncology, 43 (10) pp. 1915-1923. Peer-reviewed.
Concerning CT features used to select patients for treatment of peritoneal metastases, a pictoral essay.
Sugarbaker P.H., Sardi A., Brown G., Dromain C., Rousset P., Jelinek J.S., 2017/08. International journal of hyperthermia, 33 (5) pp. 497-504. Peer-reviewed.
Contrast-enhanced spectral mammography vs. mammography and MRI - clinical performance in a multi-reader evaluation.
Fallenberg E.M., Schmitzberger F.F., Amer H., Ingold-Heppner B., Balleyguier C., Diekmann F., Engelken F., Mann R.M., Renz D.M., Bick U. et al., 2017/07. European radiology, 27 (7) pp. 2752-2764. Peer-reviewed.
The RENAPE observational registry: rationale and framework of the rare peritoneal tumors French patient registry.
Villeneuve L., Passot G., Glehen O., Isaac S., Bibeau F., Rousset P., Gilly F.N., RENAPE Network, 2017/02/17. Orphanet journal of rare diseases, 12 (1) p. 37. Peer-reviewed.
Long-term survival after aggressive treatment of relapsed serosal or distant pseudomyxoma peritonei.
Delhorme J.B., Honoré C., Benhaim L., Dumont F., Dartigues P., Dromain C., Ducreux M., Elias D., Goéré D., 2017/01. European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology, 43 (1) pp. 159-167.
Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Peritoneal Carcinomatosis in the Elderly: A Case-Controlled, Multicenter Study.
Alyami M., Lundberg P., Kepenekian V., Goéré D., Bereder J.M., Msika S., Lorimier G., Quenet F., Ferron G., Thibaudeau E. et al., 2016/12. Annals of surgical oncology, 23 (Suppl 5) pp. 737-745. Peer-reviewed.
Imaging of neuroendocrine tumors of the pancreas.
Dromain C., Déandréis D., Scoazec J.Y., Goere D., Ducreux M., Baudin E., Tselikas L., 2016/12. Diagnostic and interventional imaging, 97 (12) pp. 1241-1257. Peer-reviewed.
A new internet tool to report peritoneal malignancy extent. PeRitOneal MalIgnancy Stage Evaluation (PROMISE) application.
Villeneuve L., Thivolet A., Bakrin N., Mohamed F., Isaac S., Valette P.J., Glehen O., Rousset P., BIG-RENAPE and RENAPE Working Groups, 2016/06. European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology, 42 (6) pp. 877-882. Peer-reviewed.
[Perception of pT1a,b pN0 breast tumor prognosis by the French oncology community: Results of the EURISTIC national survey]
Spielmann M., Dalenc F., Pointreau Y., Azria D., Classe J. M., Dromain C., Facchini T., Goncalves A., Liegeois P., Namer M. et al., 2016. Bull Cancer, 103 (2) pp. 154-63. Peer-reviewed.
Added Value of Contrast-Enhanced Spectral Mammography in Postscreening Assessment
Tardivel A. M., Balleyguier C., Dunant A., Delaloge S., Mazouni C., Mathieu M. C., Dromain C., 2016. Breast J, 22 (5) pp. 520-8. Peer-reviewed.
Diagnostic Performance of MR-guided Vacuum-Assisted Breast Biopsy: 8 Years of Experience
Ferre R., Ianculescu V., Ciolovan L., Mathieu M. C., Uzan C., Canale S., Delaloge S., Dromain C., Balleyguier C., 2016. Breast J, 22 (1) pp. 83-9. Peer-reviewed.
The challenge of rapid diagnosis in oncology: Diagnostic accuracy and cost analysis of a large-scale one-stop breast clinic
Delaloge S., Bonastre J., Borget I., Garbay J. R., Fontenay R., Boinon D., Saghatchian M., Mathieu M. C., Mazouni C., Rivera S. et al., 2016. Eur J Cancer, 66 pp. 131-137. Peer-reviewed.
Breast pain and imaging
Balleyguier C., Arfi-Rouche J., Haddag L., Canale S., Delaloge S., Dromain C., 2015. Diagn Interv Imaging, 96 (10) pp. 1009-16. Peer-reviewed.
Dual-energy contrast-enhanced spectral mammography (CESM)
Daniaux M., De Zordo T., Santner W., Amort B., Koppelstatter F., Jaschke W., Dromain C., Oberaigner W., Hubalek M., Marth C., 2015. Arch Gynecol Obstet, 292 (4) pp. 739-47. Peer-reviewed.
Added value of Virtual Touch IQ shear wave elastography in the ultrasound assessment of breast lesions
Ianculescu V., Ciolovan L. M., Dunant A., Vielh P., Mazouni C., Delaloge S., Dromain C., Blidaru A., Balleyguier C., 2014. Eur J Radiol, 83 (5) pp. 773-7. Peer-reviewed.
Bevacizumab combined with 5-FU/streptozocin in patients with progressive metastatic well-differentiated pancreatic endocrine tumours (BETTER trial)--a phase II non-randomised trial
Ducreux M., Dahan L., Smith D., O'Toole D., Lepere C., Dromain C., Vilgrain V., Baudin E., Lombard-Bohas C., Scoazec J. Y. et al., 2014. Eur J Cancer, 50 (18) pp. 3098-106. Peer-reviewed.
Bevacizumab plus capecitabine in patients with progressive advanced well-differentiated neuroendocrine tumors of the gastro-intestinal (GI-NETs) tract (BETTER trial)--a phase II non-randomised trial
Mitry E., Walter T., Baudin E., Kurtz J. E., Ruszniewski P., Dominguez-Tinajero S., Bengrine-Lefevre L., Cadiot G., Dromain C., Farace F. et al., 2014. Eur J Cancer, 50 (18) pp. 3107-15. Peer-reviewed.
Contrast-enhanced spectral mammography versus MRI: Initial results in the detection of breast cancer and assessment of tumour size
Fallenberg E. M., Dromain C., Diekmann F., Engelken F., Krohn M., Singh J. M., Ingold-Heppner B., Winzer K. J., Bick U., Renz D. M., 2014. Eur Radiol, 24 (1) pp. 256-64. Peer-reviewed.
Contrast-enhanced spectral mammography: Does mammography provide additional clinical benefits or can some radiation exposure be avoided?
Fallenberg E. M., Dromain C., Diekmann F., Renz D. M., Amer H., Ingold-Heppner B., Neumann A. U., Winzer K. J., Bick U., Hamm B. et al., 2014. Breast Cancer Res Treat, 146 (2) pp. 371-81. Peer-reviewed.
Evaluating digestive neuroendocrine tumor progression and therapeutic responses in the era of targeted therapies: state of the art
de Mestier L., Dromain C., d'Assignies G., Scoazec J. Y., Lassau N., Lebtahi R., Brixi H., Mitry E., Guimbaud R., Courbon F. et al., 2014. Endocr Relat Cancer, 21 (3) pp. R105-20. Peer-reviewed.
Liver, lung and peritoneal metastases in colorectal cancers: is the patient still curable? What should the radiologist know
Dromain C., Caramella C., Dartigues P., Goere D., Ducreux M., Deschamps F., 2014. Diagn Interv Imaging, 95 (5) pp. 513-23. Peer-reviewed.
Optimization of contrast-enhanced spectral mammography depending on clinical indication
Dromain C., Canale S., Saab-Puong S., Carton A. K., Muller S., Fallenberg E. M., 2014. J Med Imaging (Bellingham), 1 (3) p. 033506. Peer-reviewed.
Tumor growth rate is an early indicator of antitumor drug activity in phase I clinical trials
Ferte C., Fernandez M., Hollebecque A., Koscielny S., Levy A., Massard C., Balheda R., Bot B., Gomez-Roca C., Dromain C. et al., 2014. Clin Cancer Res, 20 (1) pp. 246-52. Peer-reviewed.
Whole body MRI in paediatric oncology
Canale S., Vilcot L., Ammari S., Lemery M., Bidault F., Balleyguier C., Caramella C., Dromain C., 2014. Diagn Interv Imaging, 95 (6) pp. 541-50. Peer-reviewed.
[Breast cancer imaging]
Canale S., Balleyguier C., Dromain C., 2013. Rev Prat, 63 (10) pp. 1378-83.
Adjuvant chemotherapy after resection of colorectal liver metastases in patients at high risk of hepatic recurrence: a comparative study between hepatic arterial infusion of oxaliplatin and modern systemic chemotherapy
Goere D., Benhaim L., Bonnet S., Malka D., Faron M., Elias D., Lefevre J. H., Deschamps F., Dromain C., Boige V. et al., 2013. Ann Surg, 257 (1) pp. 114-20. Peer-reviewed.
Anatomical noise in contrast-enhanced digital mammography. Part I. Single-energy imaging
Hill M. L., Mainprize J. G., Carton A. K., Muller S., Ebrahimi M., Jong R. A., Dromain C., Yaffe M. J., 2013. Med Phys, 40 (5) p. 051910. Peer-reviewed.
Anatomical noise in contrast-enhanced digital mammography. Part II. Dual-energy imaging
Hill M. L., Mainprize J. G., Carton A. K., Saab-Puong S., Iordache R., Muller S., Jong R. A., Dromain C., Yaffe M. J., 2013. Med Phys, 40 (8) p. 081907. Peer-reviewed.
Breast elasticity: principles, technique, results: an update and overview of commercially available software
Balleyguier C., Canale S., Ben Hassen W., Vielh P., Bayou E. H., Mathieu M. C., Uzan C., Bourgier C., Dromain C., 2013. Eur J Radiol, 82 (3) pp. 427-34. Peer-reviewed.
Breast elastography: the technical process and its applications
Balleyguier C., Ciolovan L., Ammari S., Canale S., Sethom S., Al Rouhbane R., Vielh P., Dromain C., 2013. Diagn Interv Imaging, 94 (5) pp. 503-13. Peer-reviewed.
Breast lesion excision sample (BLES biopsy) combining stereotactic biopsy and radiofrequency: is it a safe and accurate procedure in case of BIRADS 4 and 5 breast lesions?
Medjhoul A., Canale S., Mathieu M. C., Uzan C., Garbay J. R., Dromain C., Balleyguier C., 2013. Breast J, 19 (6) pp. 590-4. Peer-reviewed.
Computed-aided diagnosis (CAD) in the detection of breast cancer
Dromain C., Boyer B., Ferre R., Canale S., Delaloge S., Balleyguier C., 2013. Eur J Radiol, 82 (3) pp. 417-23. Peer-reviewed.
Digital breast tomosynthesis versus mammography and breast ultrasound: a multireader performance study
Thibault F., Dromain C., Breucq C., Balleyguier C. S., Malhaire C., Steyaert L., Tardivon A., Baldan E., Drevon H., 2013. Eur Radiol, 23 (9) pp. 2441-9. Peer-reviewed.
Prognostic significance of visible cardiophrenic angle lymph nodes in the presence of peritoneal metastases from colorectal cancers
Elias D., Borget I., Farron M., Dromain C., Ducreux M., Goere D., Honore C., Boige V., Dumont F., Malka D. et al., 2013. Eur J Surg Oncol, 39 (11) pp. 1214-8. Peer-reviewed.
Value of cardiophrenic angle lymph node for the diagnosis of colorectal peritoneal carcinomatosis
Caramella C., Pottier E., Borget I., Malka D., Goere D., Boige V., Honore C., Dartigues P., Dumont F., Ducreux M. et al., 2013. Eur J Cancer, 49 (18) pp. 3798-805. Peer-reviewed.
Contrast enhanced spectral mammography: better than MRI?
Thibault F., Balleyguier C., Tardivon A., Dromain C., 2012. Eur J Radiol, 81 Suppl 1 pp. S162-4. Peer-reviewed.
Dual-energy contrast-enhanced digital mammography: initial clinical results of a multireader, multicase study
Dromain C., Thibault F., Diekmann F., Fallenberg E. M., Jong R. A., Koomen M., Hendrick R. E., Tardivon A., Toledano A., 2012. Breast Cancer Res, 14 (3) pp. R94. Peer-reviewed.
Efficacy, safety, and biomarkers of single-agent bevacizumab therapy in patients with advanced hepatocellular carcinoma
Boige V., Malka D., Bourredjem A., Dromain C., Baey C., Jacques N., Pignon J. P., Vimond N., Bouvet-Forteau N., De Baere T. et al., 2012. Oncologist, 17 (8) pp. 1063-72.
Evaluation of the accuracy of a computer-aided diagnosis (CAD) system in breast ultrasound according to the radiologist's experience
Chabi M. L., Borget I., Ardiles R., Aboud G., Boussouar S., Vilar V., Dromain C., Balleyguier C., 2012. Acad Radiol, 19 (3) pp. 311-9. Peer-reviewed.
Intervention in gastro-enteropancreatic neuroendocrine tumours
Baudin E., Planchard D., Scoazec J. Y., Guigay J., Dromain C., Hadoux J., Debaere T., Elias D., Ducreux M., 2012. Best Pract Res Clin Gastroenterol, 26 (6) pp. 855-65. Peer-reviewed.
Liver/biliary injuries following chemoembolisation of endocrine tumours and hepatocellular carcinoma: lipiodol vs. drug-eluting beads
Guiu B., Deschamps F., Aho S., Munck F., Dromain C., Boige V., Malka D., Leboulleux S., Ducreux M., Schlumberger M. et al., 2012. J Hepatol, 56 (3) pp. 609-17. Peer-reviewed.
Sequential research-related biopsies in phase I trials: acceptance, feasibility and safety
Gomez-Roca C. A., Lacroix L., Massard C., De Baere T., Deschamps F., Pramod R., Bahleda R., Deutsch E., Bourgier C., Angevin E. et al., 2012. Ann Oncol, 23 (5) pp. 1301-6. Peer-reviewed.
A 14-year-old boy with mandibular tumor, spontaneous spinal fractures. Chronic recurrent multifocal osteomyelitis
Pham C. T., Canale S., Boulet B., Brugieres L., Lecarpentier T., Dromain C., 2011. Pediatr Ann, 40 (4) pp. 188-90. Peer-reviewed.
Accuracy of diffusion-weighted echo-planar MR imaging and ADC mapping in the evaluation of residual cervical carcinoma after radiation therapy
Levy A., Caramella C., Chargari C., Medjhoul A., Rey A., Zareski E., Boulet B., Bidault F., Dromain C., Balleyguier C., 2011. Gynecol Oncol, 123 (1) pp. 110-5. Peer-reviewed.
Chromogranin A measurement in metastatic well-differentiated gastroenteropancreatic neuroendocrine carcinoma: screening for false positives and a prospective follow-up study
Vezzosi D., Walter T., Laplanche A., Raoul J. L., Dromain C., Ruszniewski P., d'Herbomez M., Guigay J., Mitry E., Cadiot G. et al., 2011. Int J Biol Markers, 26 (2) pp. 94-101. Peer-reviewed.
Complete radiological response of colorectal liver metastases after chemotherapy: what can we expect?
Gaujoux S., Goere D., Dumont F., Souadka A., Dromain C., Ducreux M., Elias D., 2011. Dig Surg, 28 (2) pp. 114-20. Peer-reviewed.
Dual-energy contrast-enhanced digital mammography: initial clinical results
Dromain C., Thibault F., Muller S., Rimareix F., Delaloge S., Tardivon A., Balleyguier C., 2011. Eur Radiol, 21 (3) pp. 565-74. Peer-reviewed.
Interest of diffusion-weighted echo-planar MR imaging and apparent diffusion coefficient mapping in gynecological malignancies: a review
Levy A., Medjhoul A., Caramella C., Zareski E., Berges O., Chargari C., Boulet B., Bidault F., Dromain C., Balleyguier C., 2011. J Magn Reson Imaging, 33 (5) pp. 1020-7. Peer-reviewed.
Patients operated on for initially unresectable colorectal liver metastases with missing metastases experience a favorable long-term outcome
Goere D., Gaujoux S., Deschamp F., Dumont F., Souadka A., Dromain C., Ducreux M., Elias D., 2011. Ann Surg, 254 (1) pp. 114-8. Peer-reviewed.
Performance of (18)fluorodeoxyglucose-positron emission tomography and somatostatin receptor scintigraphy for high Ki67 (>/=10%) well-differentiated endocrine carcinoma staging
Abgral R., Leboulleux S., Deandreis D., Auperin A., Lumbroso J., Dromain C., Duvillard P., Elias D., de Baere T., Guigay J. et al., 2011. J Clin Endocrinol Metab, 96 (3) pp. 665-71. Peer-reviewed.
Results of systematic second-look surgery plus HIPEC in asymptomatic patients presenting a high risk of developing colorectal peritoneal carcinomatosis
Elias D., Honore C., Dumont F., Ducreux M., Boige V., Malka D., Burtin P., Dromain C., Goere D., 2011. Ann Surg, 254 (2) pp. 289-93. Peer-reviewed.
Role of FDG PET/CT and chest CT in the follow-up of lung lesions treated with radiofrequency ablation
Deandreis D., Leboulleux S., Dromain C., Auperin A., Coulot J., Lumbroso J., Deschamps F., Rao P., Schlumberger M., de Baere T., 2011. Radiology, 258 (1) pp. 270-6. Peer-reviewed.
Tumour growth rates and RECIST criteria in early drug development
Gomez-Roca C., Koscielny S., Ribrag V., Dromain C., Marzouk I., Bidault F., Bahleda R., Ferte C., Massard C., Soria J. C., 2011. Eur J Cancer, 47 (17) pp. 2512-6. Peer-reviewed.
[MR imaging patterns of bone marrow]
Boulet B., Caramella C., Couanet D., Balleyguier C., Bidault F., Dromain C., 2010. J Radiol, 91 (9 Pt 2) pp. 935-49. Peer-reviewed.
[Non-invasive imaging tools in colorectal cancer]
Ducreux M., Dromain C., 2010. Rev Prat, 60 (8) pp. 1071-3. Peer-reviewed.
Adrenocortical carcinoma: is the surgical approach a risk factor of peritoneal carcinomatosis?
Leboulleux S., Deandreis D., Al Ghuzlan A., Auperin A., Goere D., Dromain C., Elias D., Caillou B., Travagli J. P., De Baere T. et al., 2010. Eur J Endocrinol, 162 (6) pp. 1147-53. Peer-reviewed.
Characteristics, treatment, and outcome of breast cancers diagnosed in BRCA1 and BRCA2 gene mutation carriers in intensive screening programs including magnetic resonance imaging
Chereau E., Uzan C., Balleyguier C., Chevalier J., de Paillerets B. B., Caron O., Rimareix F., Mathieu M. C., Koskas M., Bourgier C. et al., 2010. Clin Breast Cancer, 10 (2) pp. 113-8. Peer-reviewed.
Endocrine pancreatic tumours: which are the most useful MRI sequences?
Caramella C., Dromain C., De Baere T., Boulet B., Schlumberger M., Ducreux M., Baudin E., 2010. Eur Radiol, 20 (11) pp. 2618-27. Peer-reviewed.
Hepatic metastases from neuroendocrine tumors with a "thin slice" pathological examination: they are many more than you think
Elias D., Lefevre J. H., Duvillard P., Goere D., Dromain C., Dumont F., Baudin E., 2010. Ann Surg, 251 (2) pp. 307-10. Peer-reviewed.
Optimizing the size variation threshold for the CT evaluation of response in metastatic renal cell carcinoma treated with sunitinib
Thiam R., Fournier L. S., Trinquart L., Medioni J., Chatellier G., Balvay D., Escudier B., Dromain C., Cuenod C. A., Oudard S., 2010. Ann Oncol, 21 (5) pp. 936-41. Peer-reviewed.
Prognostic markers of survival after combined mitotane- and platinum-based chemotherapy in metastatic adrenocortical carcinoma
Malandrino P., Al Ghuzlan A., Castaing M., Young J., Caillou B., Travagli J. P., Elias D., de Baere T., Dromain C., Paci A. et al., 2010. Endocr Relat Cancer, 17 (3) pp. 797-807. Peer-reviewed.
Prolonged survival of initially unresectable hepatic colorectal cancer patients treated with hepatic arterial infusion of oxaliplatin followed by radical surgery of metastases
Goere D., Deshaies I., de Baere T., Boige V., Malka D., Dumont F., Dromain C., Ducreux M., Elias D., 2010. Ann Surg, 251 (4) pp. 686-91. Peer-reviewed.
Infantile fibrosarcoma: magnetic resonance imaging findings in six cases.
Canale S., Vanel D., Couanet D., Patte C., Caramella C., Dromain C., 2009/10. European journal of radiology, 72 (1) pp. 30-37. Peer-reviewed.
Combined liver surgery and RFA for patients with gastroenteropancreatic endocrine tumors presenting with more than 15 metastases to the liver
Elias D., Goere D., Leroux G., Dromain C., Leboulleux S., de Baere T., Ducreux M., Baudin E., 2009. Eur J Surg Oncol, 35 (10) pp. 1092-7. Peer-reviewed.
Comparison between RECIST evaluations and variations in tumor growth dynamics in patients included in phase I trials
Gomez-Roca C. A., Koscielny S., Dromain C., Marzouk I., Bidault F., Bahleda R., Ferte C., Massard C., Soria J., 2009. J Clin Oncol, 27 (15_suppl) p. 2515.
Comparison of cytopathological and histological results in 1,053 fine-needle aspiration cytology of breast lesions performed in a one-stop clinic
Borget I., Caramella C., Balleyguier C., Suciu V., Uzan C., Domont J., Mathieu M., Dromain C., Delaloge S., Vielh P., 2009. J Clin Oncol, 27 (15_suppl) p. 635.
Contrast-enhanced digital mammography
Dromain C., Balleyguier C., Adler G., Garbay J. R., Delaloge S., 2009. Eur J Radiol, 69 (1) pp. 34-42. Peer-reviewed.
Dynamic optical breast imaging: a novel technique to detect and characterize tumor vessels
Fournier L. S., Vanel D., Athanasiou A., Gatzemeier W., Masuykov I. V., Padhani A. R., Dromain C., Galetti K., Sigal R., Costa A. et al., 2009. Eur J Radiol, 69 (1) pp. 43-9. Peer-reviewed.
Follow-up of hepatic and peritoneal metastases of gastrointestinal tumors (GIST) under Imatinib therapy requires different criteria of radiological evaluation (size is not everything!!!)
Mabille M., Vanel D., Albiter M., Le Cesne A., Bonvalot S., Le Pechoux C., Terrier P., Shapeero L. G., Dromain C., 2009. Eur J Radiol, 69 (2) pp. 204-8. Peer-reviewed.
Hepatic resection of initially unresectable liver metastases from colorectal cancer after hepatic arterial infusion of oxaliplatin and systemic 5-fluorouracil and leucovorin
Goere, D., Sr. , Dsehais I., de Baere T., Boige V., Malka D., Bonnet S., Dromain C., Elias D., Ducreux M., 2009. J Clin Oncol, 27 (15_suppl) pp. e15015.
Liposarcoma or lipoma: does genetics change classic imaging criteria?
Bidault F., Vanel D., Terrier P., Jalaguier A., Bonvalot S., Pedeutour F., Couturier J. M., Dromain C., 2009. Eur J Radiol, 72 (1) pp. 22-6. Peer-reviewed.
New potential and applications of contrast-enhanced ultrasound of the breast: Own investigations and review of the literature
Balleyguier C., Opolon P., Mathieu M. C., Athanasiou A., Garbay J. R., Delaloge S., Dromain C., 2009. Eur J Radiol, 69 (1) pp. 14-23. Peer-reviewed.
Prognostic factors influencing survival from metastatic (stage IV) gastroenteropancreatic well-differentiated endocrine carcinoma
Durante C., Boukheris H., Dromain C., Duvillard P., Leboulleux S., Elias D., de Baere T., Malka D., Lumbroso J., Guigay J. et al., 2009. Endocr Relat Cancer, 16 (2) pp. 585-97. Peer-reviewed.
[Alternative breast biopsies]
Balleyguler C., Bidault F., Caillet H., Dromain C., 2008. Rev Prat, 58 (14) pp. 1513-6. Peer-reviewed.
Comparison between the minimum margin defined on preoperative imaging and the final surgical margin after hepatectomy for cancer: how to manage it?
Elias D., Bonnet S., Honore C., Kohneh-Shahri N., Tomasic G., Lassau N., Dromain C., Goere D., 2008. Ann Surg Oncol, 15 (3) pp. 777-81. Peer-reviewed.
Hepatic arterial infusion of oxaliplatin and intravenous LV5FU2 in unresectable liver metastases from colorectal cancer after systemic chemotherapy failure
Boige V., Malka D., Elias D., Castaing M., De Baere T., Goere D., Dromain C., Pocard M., Ducreux M., 2008. Ann Surg Oncol, 15 (1) pp. 219-26. Peer-reviewed.
Hepatic malignancies: percutaneous radiofrequency ablation during percutaneous portal or hepatic vein occlusion
de Baere T., Deschamps F., Briggs P., Dromain C., Boige V., Hechelhammer L., Abdel-Rehim M., Auperin A., Goere D., Elias D., 2008. Radiology, 248 (3) pp. 1056-66. Peer-reviewed.
Peritoneal pseudomyxoma: results of a systematic policy of complete cytoreductive surgery and hyperthermic intraperitoneal chemotherapy
Elias D., Honore C., Ciuchendea R., Billard V., Raynard B., Lo Dico R., Dromain C., Duvillard P., Goere D., 2008. Br J Surg, 95 (9) pp. 1164-71. Peer-reviewed.
Prediction and diagnosis of bone metastases in well-differentiated gastro-entero-pancreatic endocrine cancer: a prospective comparison of whole body magnetic resonance imaging and somatostatin receptor scintigraphy
Leboulleux S., Dromain C., Vataire A. L., Malka D., Auperin A., Lumbroso J., Duvillard P., Elias D., Hartl D. M., De Baere T. et al., 2008. J Clin Endocrinol Metab, 93 (8) pp. 3021-8. Peer-reviewed.
Progression of medullary thyroid carcinoma: assessment with calcitonin and carcinoembryonic antigen doubling times
Laure Giraudet A., Al Ghulzan A., Auperin A., Leboulleux S., Chehboun A., Troalen F., Dromain C., Lumbroso J., Baudin E., Schlumberger M., 2008. Eur J Endocrinol, 158 (2) pp. 239-46. Peer-reviewed.
Results of systematic second-look surgery in patients at high risk of developing colorectal peritoneal carcinomatosis
Elias D., Goere D., Di Pietrantonio D., Boige V., Malka D., Kohneh-Shahri N., Dromain C., Ducreux M., 2008. Ann Surg, 247 (3) pp. 445-50. Peer-reviewed.
Staging of peritoneal carcinomatosis: enhanced CT vs. PET/CT
Dromain C., Leboulleux S., Auperin A., Goere D., Malka D., Lumbroso J., Schumberger M., Sigal R., Elias D., 2008. Abdom Imaging, 33 (1) pp. 87-93. Peer-reviewed.
The differential response to chemotherapy of ovarian metastases from colorectal carcinoma
Goere D., Daveau C., Elias D., Boige V., Tomasic G., Bonnet S., Pocard M., Dromain C., Ducreux M., Lasser P. et al., 2008. Eur J Surg Oncol, 34 (12) pp. 1335-9. Peer-reviewed.
BIRADS classification in mammography
Balleyguier C., Ayadi S., Van Nguyen K., Vanel D., Dromain C., Sigal R., 2007. Eur J Radiol, 61 (2) pp. 192-4. Peer-reviewed.
Complete, long-standing regression of hepatocellular carcinoma after somatostatin analogue treatment
Rahmi G., Malka D., Tomasic G., Dromain C., Ducreux M., Boige V., 2007. J Clin Oncol, 25 (16) pp. e15-6. Peer-reviewed.
Imaging medullary thyroid carcinoma with persistent elevated calcitonin levels
Giraudet A. L., Vanel D., Leboulleux S., Auperin A., Dromain C., Chami L., Ny Tovo N., Lumbroso J., Lassau N., Bonniaud G. et al., 2007. J Clin Endocrinol Metab, 92 (11) pp. 4185-90. Peer-reviewed.
Outcome of posthepatectomy-missing colorectal liver metastases after complete response to chemotherapy: impact of adjuvant intra-arterial hepatic oxaliplatin
Elias D., Goere D., Boige V., Kohneh-Sharhi N., Malka D., Tomasic G., Dromain C., Ducreux M., 2007. Ann Surg Oncol, 14 (11) pp. 3188-94. Peer-reviewed.
Prognostic parameters of metastatic adrenocortical carcinoma
Assie G., Antoni G., Tissier F., Caillou B., Abiven G., Gicquel C., Leboulleux S., Travagli J. P., Dromain C., Bertagna X. et al., 2007. J Clin Endocrinol Metab, 92 (1) pp. 148-54. Peer-reviewed.
Pulmonary and extrapulmonary poorly differentiated large cell neuroendocrine carcinomas: diagnostic and prognostic features
Faggiano A., Sabourin J. C., Ducreux M., Lumbroso J., Duvillard P., Leboulleux S., Dromain C., Colao A., Schlumberger M., Baudin E., 2007. Cancer, 110 (2) pp. 265-74. Peer-reviewed.
Cancers of the biliary system
Malka David, Dromain Clarisse, Landi Bruno, Prat Frédéric, De Baere Thierry, Delpero Jean-Robert, Chiche Laurence, 2006/09. Gastroentérologie Clinique et Biologique, 30 (Suppl. 1) pp. 62-74. Peer-reviewed.
[Imaging strategy for staging and follow-up of endocrine tumors]
Dromain C., Baudin E., 2006. Bull Cancer, 93 (12) pp. 1183-9. Peer-reviewed.
A phase II study of irinotecan with 5-fluorouracil and leucovorin in patients with pretreated gastroenteropancreatic well-differentiated endocrine carcinomas
Ducreux M. P., Boige V., Leboulleux S., Malka D., Kergoat P., Dromain C., Elias D., de Baere T., Sabourin J. C., Duvillard P. et al., 2006. Oncology, 70 (2) pp. 134-40. Peer-reviewed.
Chemoembolization for liver metastases from medullary thyroid carcinoma
Fromigue J., De Baere T., Baudin E., Dromain C., Leboulleux S., Schlumberger M., 2006. J Clin Endocrinol Metab, 91 (7) pp. 2496-9. Peer-reviewed.
Diagnostic and prognostic value of 18-fluorodeoxyglucose positron emission tomography in adrenocortical carcinoma: a prospective comparison with computed tomography
Leboulleux S., Dromain C., Bonniaud G., Auperin A., Caillou B., Lumbroso J., Sigal R., Baudin E., Schlumberger M., 2006. J Clin Endocrinol Metab, 91 (3) pp. 920-5. Peer-reviewed.
Evaluation of tumor angiogenesis of breast carcinoma using contrast-enhanced digital mammography
Dromain C., Balleyguier C., Muller S., Mathieu M. C., Rochard F., Opolon P., Sigal R., 2006. AJR Am J Roentgenol, 187 (5) pp. W528-37. Peer-reviewed.
Midterm local efficacy and survival after radiofrequency ablation of lung tumors with minimum follow-up of 1 year: prospective evaluation
de Baere T., Palussiere J., Auperin A., Hakime A., Abdel-Rehim M., Kind M., Dromain C., Ravaud A., Tebboune N., Boige V. et al., 2006. Radiology, 240 (2) pp. 587-96. Peer-reviewed.
Splenic infarction and bevacizumab
Malka D., Van den Eynde M., Boige V., Dromain C., Ducreux M., 2006. Lancet Oncol, 7 (12) p. 1038. Peer-reviewed.
Thyroid metastases from colorectal cancer: the Institut Gustave Roussy experience
Lievre A., Leboulleux S., Boige V., Travagli J. P., Dromain C., Elias D., Ducreux M., Malka D., 2006. Eur J Cancer, 42 (12) pp. 1756-9. Peer-reviewed.
Usefulness of guiding needles for radiofrequency ablative treatment of liver tumors
de Baere T., Rehim M. A., Teriitheau C., Deschamps F., Lapeyre M., Dromain C., Boige V., Ducreux M., Elias D., 2006. Cardiovasc Intervent Radiol, 29 (4) pp. 650-4. Peer-reviewed.
[Endocrine pancreas]
Dromain C., Baudin E., 2005. J Radiol, 86 (6 Pt 2) pp. 797-804; quiz 805. Peer-reviewed.
Artificially induced pneumothorax for percutaneous transthoracic radiofrequency ablation of tumors in the hepatic dome: initial experience
de Baere T., Dromain C., Lapeyre M., Briggs P., Duret J. S., Hakime A., Boige V., Ducreux M., 2005. Radiology, 236 (2) pp. 666-70. Peer-reviewed.
Detection of liver metastases from endocrine tumors: a prospective comparison of somatostatin receptor scintigraphy, computed tomography, and magnetic resonance imaging
Dromain C., de Baere T., Lumbroso J., Caillet H., Laplanche A., Boige V., Ducreux M., Duvillard P., Elias D., Schlumberger M. et al., 2005. J Clin Oncol, 23 (1) pp. 70-8. Peer-reviewed.
Dynamic optical breast imaging: a new technique to visualise breast vessels: comparison with breast MRI and preliminary results
Athanasiou A., Vanel D., Balleyguier C., Fournier L., Mathieu M. C., Delaloge S., Dromain C., 2005. Eur J Radiol, 54 (1) pp. 72-9. Peer-reviewed.
Incidence of unsuspected and treatable metastatic disease associated with operable colorectal liver metastases discovered only at laparotomy (and not treated when performing percutaneous radiofrequency ablation)
Elias D., Sideris L., Pocard M., de Baere T., Dromain C., Lassau N., Lasser P., 2005. Ann Surg Oncol, 12 (4) pp. 298-302. Peer-reviewed.
Intra-abdominal desmoplastic small round cell tumors: CT findings and clinicopathological correlations in 13 cases
Chouli M., Viala J., Dromain C., Fizazi K., Duvillard P., Vanel D., 2005. Eur J Radiol, 54 (3) pp. 438-42. Peer-reviewed.
Role of computed tomography in the follow-up of hepatic and peritoneal metastases of GIST under imatinib mesylate treatment: a prospective study of 54 patients
Vanel D., Albiter M., Shapeero L., Le Cesne A., Bonvalot S., Le Pechoux C., Terrier P., Petrow P., Caillet H., Dromain C., 2005. Eur J Radiol, 54 (1) pp. 118-23. Peer-reviewed.
Role of contrast-enhanced color Doppler ultrasonography and dynamic flow in the evaluation of hepatic tumors treated with radiofrequency
Lassau N., Lamuraglia M., Chawi I., Smayra T., Dromain C., Koscielny S., de Baere T., Leclere J., Roche A., 2005. Cancer Imaging, 5 pp. 39-45. Peer-reviewed.
[Colorectal cancer: contribution of new diagnostic tools]
Dromain C., Ducreux M., 2004. Rev Prat, 54 (2) pp. 151-4. Peer-reviewed.
Biliary tract neoplasms: update 2003
Malka D., Boige V., Dromain C., Debaere T., Pocard M., Ducreux M., 2004. Curr Opin Oncol, 16 (4) pp. 364-71. Peer-reviewed.
Evolution of missing colorectal liver metastases following inductive chemotherapy and hepatectomy
Elias D., Youssef O., Sideris L., Dromain C., Baton O., Boige V., Ducreux M., 2004. J Surg Oncol, 86 (1) pp. 4-9. Peer-reviewed.
Intraductal cooling of the main bile ducts during radiofrequency ablation prevents biliary stenosis
Elias D., Sideris L., Pocard M., Dromain C., De Baere T., 2004. J Am Coll Surg, 198 (5) pp. 717-21. Peer-reviewed.
MR imaging in the evaluation of isolated limb perfusion: a prospective study of 18 cases
Vanel D., Bonvalot S., Guinebretiere J. M., Petrow P., Dromain C., Caillet H., 2004. Skeletal Radiol, 33 (3) pp. 150-6. Peer-reviewed.
The doxorubicin-streptozotocin combination for the treatment of advanced well-differentiated pancreatic endocrine carcinoma; a judicious option?
Delaunoit T., Ducreux M., Boige V., Dromain C., Sabourin J. C., Duvillard P., Schlumberger M., de Baere T., Rougier P., Ruffie P. et al., 2004. Eur J Cancer, 40 (4) pp. 515-20. Peer-reviewed.
Adverse events during radiofrequency treatment of 582 hepatic tumors
de Baere T., Risse O., Kuoch V., Dromain C., Sengel C., Smayra T., Gamal El Din M., Letoublon C., Elias D., 2003. AJR Am J Roentgenol, 181 (3) pp. 695-700. Peer-reviewed.
Computed tomographic features of peritoneal carcinomatosis treated by intraperitoneal chemohyperthermia
Dromain C., Bisdorff A., Elias D., Antoun S., Boige V., Lasser P., Sigal R., 2003. J Comput Assist Tomogr, 27 (3) pp. 327-32. Peer-reviewed.
Liver resection (and associated extrahepatic resections) for metastatic well-differentiated endocrine tumors: a 15-year single center prospective study
Elias D., Lasser P., Ducreux M., Duvillard P., Ouellet J. F., Dromain C., Schlumberger M., Pocard M., Boige V., Miquel C. et al., 2003. Surgery, 133 (4) pp. 375-82. Peer-reviewed.
MR imaging of hepatic metastases caused by neuroendocrine tumors: comparing four techniques
Dromain C., de Baere T., Baudin E., Galline J., Ducreux M., Boige V., Duvillard P., Laplanche A., Caillet H., Lasser P. et al., 2003. AJR Am J Roentgenol, 180 (1) pp. 121-8. Peer-reviewed.
Normal intratumoral lymph node in a patient with lipoma mimicking liposarcoma
Petrow P., Dromain C., Guinebretiere J. M., Vanel D., 2003. AJR Am J Roentgenol, 181 (2) pp. 569-70. Peer-reviewed.
Deconvolution technique for measuring tissue perfusion by dynamic CT: application to normal and metastatic liver.
Cuenod C.A., Leconte I., Siauve N., Frouin F., Dromain C., Clément O., Frija G., 2002/05. Academic radiology, 9 (Suppl 1) pp. S205-11. Peer-reviewed.
Biologie et imagerie des tumeurs neuro-endocrines [Biology and imaging of neuroendocrine tumors]
Baudin E., Dromain C., 2002/02/01. La Revue du praticien, 52 (3) pp. 268-273. Peer-reviewed.
[Biology and imaging of neuroendocrine tumors]
Baudin E., Dromain C., 2002. Rev Prat, 52 (3) pp. 268-73. Peer-reviewed.
[Radiologic-pathologic correlations in breast diseases]
Tardivon A., Guinebretiere J., Dromain C., 2002. J Radiol, 83 (4 Pt 2) pp. 555-63. Peer-reviewed.
Hepatic tumors treated with percutaneous radio-frequency ablation: CT and MR imaging follow-up
Dromain C., de Baere T., Elias D., Kuoch V., Ducreux M., Boige V., Petrow P., Roche A., Sigal R., 2002. Radiology, 223 (1) pp. 255-62. Peer-reviewed.
Histological findings in surgical specimens after core biopsy of the breast
Tardivon A. A., Guinebretiere J. M., Dromain C., Deghaye M., Caillet H., Georgin V., 2002. Eur J Radiol, 42 (1) pp. 40-51. Peer-reviewed.
Imaging and management of nonpalpable lesions of the breast
Tardivon A. A., Guinebretiere J. M., Dromain C., Vanel D., 2002. Eur J Radiol, 42 (1) pp. 2-9. Peer-reviewed.
Percutaneous radiofrequency ablation of hepatic tumors during temporary venous occlusion
de Baere T., Bessoud B., Dromain C., Ducreux M., Boige V., Lassau N., Smayra T., Girish B. V., Roche A., Elias D., 2002. AJR Am J Roentgenol, 178 (1) pp. 53-9. Peer-reviewed.
Radio frequency ablation of renal cell carcinoma: preliminary clinical experience
de Baere T., Kuoch V., Smayra T., Dromain C., Cabrera T., Court B., Roche A., 2002. J Urol, 167 (5) pp. 1961-4. Peer-reviewed.
Early changes in liver perfusion caused by occult metastases in rats: detection with quantitative CT
Cuenod C., Leconte I., Siauve N., Resten A., Dromain C., Poulet B., Frouin F., Clement O., Frija G., 2001. Radiology, 218 (2) pp. 556-61. Peer-reviewed.
MRI of bone marrow disorders
Vanel D., Dromain C., Tardivon A., 2000. Eur Radiol, 10 (2) pp. 224-9. Peer-reviewed.
Radiofrequency ablation of 100 hepatic metastases with a mean follow-up of more than 1 year
de Baere T., Elias D., Dromain C., Din M. G., Kuoch V., Ducreux M., Boige V., Lassau N., Marteau V., Lasser P. et al., 2000. AJR Am J Roentgenol, 175 (6) pp. 1619-25. Peer-reviewed.
[Percutaneous radiofrequency ablation of hepatic metastases. Preliminary experience]
De Baere T., Elias D., Ducreux M., Dromain C., Kuach V., Gamal El Din M., Sobotka A., Lasser P., Roche A., 1999. Gastroenterol Clin Biol, 23 (11) pp. 1128-33. Peer-reviewed.
Unicentre - CH-1015 Lausanne
Tél. +41 21 692 11 11
Swiss University